RESMED INC — Director's Dealing 2015

Feb 5, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-02-03

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-03	ResMed Common Stock	S	500	$62.35	Disposed	58620.354	Indirect
2015-02-03	ResMed Common Stock	M	5833	$19.25	Acquired	64453.354	Indirect
2015-02-03	ResMed Common Stock	S	5833	$62.35	Disposed	58620.354	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-03	ResMed Common Stock Options	$19.25	M	5833	Disposed	2016-02-03	ResMed Common Stock (5833)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	42662	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.